Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-062348
Filing Date
2022-05-18
Accepted
2022-05-18 12:34:25
Documents
2
Group Members
ALEX NOAH INVESTORS, INC.JONATHAN I. COPEJOSHUA B. SCHEINFELDLINCOLN PARK CAPITAL, LLCROCKLEDGE CAPITAL CORP

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2215960d1_sc13g.htm SC 13G 108661
2 EXHIBIT 1 tm2215960d1_ex1.htm EX-99.1 17581
  Complete submission text file 0001104659-22-062348.txt   128007
Mailing Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654
Business Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654 312-822-9300
Lincoln Park Capital Fund, LLC (Filed by) CIK: 0001592644 (see all company filings)

EIN.: 010939472 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G

Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Subject) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92206 | Film No.: 22937842
SIC: 2834 Pharmaceutical Preparations